Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility

Cardiovasc Res. 2006 Feb 15;69(3):688-96. doi: 10.1016/j.cardiores.2005.08.023. Epub 2005 Sep 23.

Abstract

Objective: Matrix metalloproteinase-2 (MMP-2) plays a major role in dysfunctional ventricular remodeling following myocardial injury induced by ischemia/reperfusion and heart failure. To directly assess the role of MMP-2 in the absence of superimposed injury, we generated cardiac-specific, constitutively active MMP-2 transgenic mice.

Methods: Morphologic and functional studies were carried out using both intact and demembranated (skinned) right ventricular trabeculae dissected from hearts of 8-month-old MMP-2 transgenic mice and wild-type controls (WT).

Results: Electron micrographs showed that compared to WT, MMP-2 myocardium had no gross, ultrastructural changes (no myocyte dropout or gross fibrosis). However, MMP-2 myocardium contained fibroblasts with abundant rough endoplasmic reticulum, consistent with an activated synthetic phenotype, suggesting extracellular matrix remodeling in MMP-2 trabeculae. Consistent with remodeling, mechanical studies found increased stiffness of intact unstimulated trabeculae (increasing sarcomere lengths from 2 to 2.3 microm caused a greater rise of passive muscle force for MMP-2 trabeculae versus WT). With electrical stimulation, MMP-2 trabeculae generated substantially less active force at all sarcomere lengths. Moreover, inotropic responses to increases of bath [Ca2+], pacing frequency, and isoproterenol were all significantly reduced versus WT trabeculae. Skinned fiber assessment of myofilament function revealed that maximum Ca2+-activated force of skinned MMP-2 trabeculae was reduced to approximately 50% of WT, suggesting a myofilament contraction defect.

Conclusion: Cardiac-specific, constitutively active MMP-2 expression leads to impaired contraction and diminished responses to inotropic stimulation. These findings indicate that MMP-2 can directly impair ventricular function in the absence of superimposed injury.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / ultrastructure
  • Adenylyl Cyclases / metabolism
  • Adrenergic beta-Antagonists / pharmacology
  • Animals
  • Calcium / metabolism
  • Colforsin / pharmacology
  • Electric Stimulation
  • Endoplasmic Reticulum / ultrastructure
  • Fibroblasts / ultrastructure
  • In Vitro Techniques
  • Isoproterenol / pharmacology
  • Matrix Metalloproteinase 2 / genetics
  • Matrix Metalloproteinase 2 / metabolism*
  • Mice
  • Mice, Transgenic
  • Microscopy, Electron
  • Microscopy, Fluorescence
  • Myocardial Contraction
  • Myocardium / enzymology*
  • Myocardium / metabolism
  • Myocardium / ultrastructure*
  • Sarcomeres / ultrastructure
  • Stimulation, Chemical
  • Ventricular Dysfunction, Left / enzymology
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Remodeling

Substances

  • Adrenergic beta-Antagonists
  • Colforsin
  • Matrix Metalloproteinase 2
  • Adenylyl Cyclases
  • Isoproterenol
  • Calcium